|
1
|
Whitsett JA, Wert SE and Weaver TE:
Alveolar surfactant homeostasis and the pathogenesis of pulmonary
disease. Annu Rev Med. 61:105–119. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hoffman AM and Ingenito EP: Alveolar
epithelial stem and progenitor cells: emerging evidence for their
role in lung regeneration. Curr Med Chem. 19:6003–6008. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tsuji T, Aoshiba K and Nagai A: Alveolar
cell senescence exacerbates pulmonary inflammation in patients with
chronic obstructive pulmonary disease. Respiration. 80:59–70. 2010.
View Article : Google Scholar
|
|
4
|
Miyake Y, Kaise H, Isono K, Koseki H,
Kohno K and Tanaka M: Protective role of macrophages in
noninflammatory lung injury caused by selective ablation of
alveolar epithelial type II Cells. J Immunol. 178:5001–5009. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Corti M, Brody AR and Harrison JH:
Isolation and primary culture of murine alveolar type II cells. Am
J Respir Cell Mol Biol. 14:309–315. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ehrhardt C, Kim KJ and Lehr CM: Isolation
and culture of human alveolar epithelial cells. Methods Mol Med.
107:207–216. 2005.PubMed/NCBI
|
|
7
|
Fujino N, Kubo H, Suzuki T, et al:
Isolation of alveolar epithelial type II progenitor cells from
adult human lungs. Lab Invest. 91:363–378. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gaur M, Ritner C, Sievers R, Pedersen A,
Prasad M, Bernstein HS and Yeqhiazarians Y: Timed inhibition of
p38MAPK directs accelerated differentiation of human embryonic stem
cells into cardiomyocytes. Cytotherapy. 12:807–817. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Muguruma K and Sasai Y: In vitro
recapitulation of neural development using embryonic stem cells:
from neurogenesis to histogenesis. Dev Growth Differ. 54:349–357.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Samadikuchaksaraei A and Bishop AE:
Derivation and characterization of alveolar epithelial cells from
murine embryonic stem cells in vitro. Methods Mol Biol.
330:233–248. 2006.PubMed/NCBI
|
|
11
|
Wang D, Haviland DL, Burns AR, Zsiqmond E
and Wetsel RA: A pure population of lung alveolar epithelial type
II cells derived from human embryonic stem cells. Proc Natl Acad
Sci USA. 104:4449–4454. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang D, Morales JE, Calame DG, Alcorn JL
and Wetsel RA: Transplantation of human embryonic stem cell-derived
alveolar epithelial type II cells abrogates acute lung injury in
mice. Mol Ther. 18:625–634. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sugarman J: Human stem cell ethics: beyond
the embryo. Cell Stem Cell. 2:529–533. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsai MS, Lee JL, Chang YJ and Hwang SM:
Isolation of human multipotent mesenchymal stem cells from
second-trimester amniotic fluid using a novel two-stage culture
protocol. Hum Reprod. 19:1450–1456. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sessarego N, Parodi A, Podestà M, et al:
Multipotent mesenchymal stromal cells from amniotic fluid: solid
perspectives for clinical application. Haematologica. 93:339–346.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Joo S, Ko IK, Atala A, Yoo JJ and Lee SJ:
Amniotic fluid-derived stem cells in regenerative medicine
research. Arch Pharm Res. 35:271–280. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hartmann K, Raabe O, Wenisch S and Arnhold
S: Amniotic fluid derived stem cells give rise to neuron-like cells
without a further differentiation potential into retina-like cells.
Am J Stem Cells. 2:108–118. 2013.PubMed/NCBI
|
|
18
|
Sun H, Feng K, Hu J, Soker S, Atala A and
Ma PX: Osteogenic differentiation of human amniotic fluid-derived
stem cells induced by bone morphogenetic protein-7 and enhanced by
nanofibrous scaffolds. Biomaterials. 31:1133–1139. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Carraro G, Perin L, Sedrakyan S, et al:
Human amniotic fluid stem cells can integrate and differentiate
into epithelial lung lineages. Stem Cells. 26:2902–2911. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Perin L, Sedrakyan S, Da Sacco S and De
Filippo R: Characterization of human amniotic fluid stem cells and
their pluripotential capability. Methods Cell Biol. 86:85–99. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
De Coppi P, Bartsch G Jr, Siddiqui MM, et
al: Isolation of amniotic stem cell lines with potential for
therapy. Nat Biotechnol. 25:100–106. 2007.PubMed/NCBI
|
|
22
|
Roubelakis MG, Trohatou O and Anagnou NP:
Amniotic fluid and amniotic membrane stem cells: marker discovery.
Stem Cells Int. 2012:1078362012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Benavides OM, Petsche JJ, Moise KJ Jr,
Johnson A and Jacot JG: Evaluation of endothelial cells
differentiated from amniotic fluid-derived stem cells. Tissue Eng
Part A. 18:1123–1131. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tondeur S, Assou S, Nadal L, Hamamah S and
De Vos J: Biology and potential of human embryonic stem cells. Ann
Biol Clin (Paris). 66:241–247. 2008.(In French).
|
|
25
|
Sisson TH, Mendez M, Choi K, et al:
Targeted injury of type II alveolar epithelial cells induces
pulmonary fibrosis. Am J Respir Crit Care Med. 181:254–263. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kuwano K: Epithelial cell apoptosis and
lung remodeling. Cell Mol Immunol. 4:419–429. 2007.
|
|
27
|
Zhao CZ, Fang XC, Wang D, Tang FD and Wang
XD: Involvement of type II pneumocytes in the pathogenesis of
chronic obstructive pulmonary disease. Respir Med. 104:1391–1395.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Antonucci I, Pantalone A, Tete S, Salini
V, Borlongan CV, Hess D and Stuppia L: Amniotic fluid stem cells: a
promising therapeutic resource for cell-based regenerative therapy.
Curr Pharm Des. 18:1846–1863. 2012.PubMed/NCBI
|
|
29
|
Rippon HJ, Polak JM, Qin M and Bishop AE:
Derivation of distal lung epithelial progenitors from murine
embryonic stem cells using a novel three-step differentiation
protocol. Stem Cells. 24:1389–1398. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kubo A, Shinozaki K, Shannon JM, et al:
Development of definitive endoderm from embryonic stem cells in
culture. Development. 131:1651–1662. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Massagué J and Gomis RR: The logic of
TGFbeta signaling. FEBS Lett. 580:2811–2820. 2006.PubMed/NCBI
|
|
32
|
Cao Y, Siegel D and Knöchel W: Xenopus POU
factors of subclass V inhibit activin/nodal signaling during
gastrulation. Mech Dev. 123:614–625. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hansson M, Olesen DR, Peterslund JM, et
al: A late requirement for Wnt and FGF signaling during
activin-induced formation of foregut endoderm from mouse embryonic
stem cells. Dev Biol. 330:286–304. 2009. View Article : Google Scholar : PubMed/NCBI
|
